ASCENDIA PHARMACEUTICALS
Dead / Cancelled — Cancelled — Section 18 (TTAB) (as of 26 Jul 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85942215
- Registration number
- 4566570
- Mark type
- Stylized text
- Filed
- 24 May 2013
- Published for opposition
- 29 Apr 2014
- Registered
- 15 Jul 2014
- Attorney of record
- James Klobucar
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services
Owner
- ASCENDIA PHARMACEUTICALS INC., NORTH BRUNSWICK, NJ, US
- Ascendia Pharmaceuticals LLC, North Brunswick, NJ, US
- Ascendia Pharmaceuticals LLC, North Brunswick, NJ, US
- Ascendia Pharmaceuticals LLC, North Brunswick, NJ, US
Prosecution history
- 26 Jul 2024 — CANCELLED SECTION 18-TOTAL
- 26 Jul 2024 — CANCELLATION TERMINATED NO. 999999
- 18 Jun 2024 — CT DECISION: DISMISSED
- 15 Jul 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Apr 2022 — CANCELLATION GRANTED NO. 999999
- 14 Feb 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 14 Feb 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Feb 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 15 Dec 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 May 2021 — NOTICE OF SUIT
- 09 Mar 2021 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 09 Dec 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Sept 2020 — TEAS SECTION 8 & 15 RECEIVED
- 15 Jul 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Apr 2017 — CANCELLATION INSTITUTED NO. 999999